Taken together, our results demonstrated the involvement of STAT3 signaling in the mechanism of action of chelidonine in human uveal melanoma cells, which raises the applicability of this alkaloid in the combinational or multimodal therapies of uveal melanomas and possibly other solid tumors. Here, STAT3 is linked to uveal melanoma.